Northwest Biotherapeutics Inc (NWBO)

CIK 1072379 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Northwest Biotherapeutics Inc.

Recent SEC filings

FiledFormAccession number
Aug 14, 202610-Q0001104659-26-097188
Jul 31, 2026424B50001104659-26-089290
Jul 31, 20268-K0001104659-26-089293
Jul 20, 20268-K0001104659-26-084743
May 15, 202610-Q0001104659-26-062661
Apr 20, 2026EFFECT9999999995-26-001251
Apr 16, 2026POS AM0001104659-26-044463
Apr 15, 202610-K0001104659-26-043806
Apr 7, 20268-K0001104659-26-040260
Mar 31, 2026NT 10-K0001104659-26-037871
Jan 15, 20268-K0001104659-26-004146
Jan 2, 20268-K0001104659-26-000243
Nov 28, 2025DEF 14A0001104659-25-116966
Nov 25, 2025424B50001104659-25-116045
Nov 25, 2025EFFECT9999999995-25-003389
Nov 20, 20258-K0001104659-25-114627
Nov 19, 2025PRE 14A0001104659-25-114107
Nov 14, 202510-Q0001104659-25-112676
Oct 31, 20258-K0001104659-25-104812
Oct 30, 20258-K0001104659-25-104427
Oct 24, 20258-K0001104659-25-102049
Oct 24, 2025S-30001104659-25-101916
Oct 14, 20258-K0001104659-25-099196
Aug 14, 202510-Q0001410578-25-001825
Jul 1, 2025424B50001104659-25-064804